Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma

Journal of Thoracic Oncology

Volumn 8, Issue 2, 2013, Pages 238-245

  Gomez, Daniel R ^a   Hong, David S ^b   Allen, Pamela K ^a   Welsh, James S ^a   Mehran, Reza J ^b   Tsao, Anne S ^a   Liao, Zhongxing ^a   Bilton, Stephen D ^a   Komaki, Ritsuko ^a   Rice, David C ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b Thoracic and Cardiovascular Surgery   (United States)

Author keywords

Extrapleural Pneumonectomy; Intensity modulated radiotherapy; Malignant pleural mesothelioma

Indexed keywords

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLEEDING; BRONCHOPLEURAL FISTULA; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CARDIOTOXICITY; CEREBROVASCULAR ACCIDENT; CHYLOTHORAX; DEEP VEIN THROMBOSIS; DISEASE COURSE; DYSPNEA; EMPYEMA; ESOPHAGITIS; EXPIRATORY RESERVE VOLUME; EXSANGUINATION; FEMALE; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL TOXICITY; HEART ATRIUM ARRHYTHMIA; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KAPLAN MEIER METHOD; LOCAL RECURRENCE FREE SURVIVAL; LUNG EMBOLISM; LUNG RESECTION; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NAUSEA; OVERALL SURVIVAL; PERICARDIAL EFFUSION; PLEURA MESOTHELIOMA; PLEURISY; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT LARYNGEAL NERVE PALSY; SCORING SYSTEM; SEPSIS; SEROMA; SHOCK; SKIN TOXICITY; TREATMENT FAILURE; TREATMENT PLANNING;

EID: 84873100377     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31827740f0     Document Type: Article

References (26)

1. Treasure T, Lang-Lazdunski L, Waller D, et al.; MARS trialists. Extrapleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011;12:763-772.
2. Wolf AS, Daniel J, Sugarbaker DJ. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication. Semin Thorac Cardiovasc Surg 2009;21:132-148.
3. Rusch VW, Rosenzweig K, Venkatraman E, et al: A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. Journal of Thoracic and Cardiovascular Surgery 122:788-795, 2001.
4. Yajnik S, Rosenzweig KE, Mychalczak B, et al: Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. International Journal of Radiation Oncology Biology Physics 56:1319- 1326, 2003
5. Rice DC, Stevens CW, Correa AM, et al. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 2007;84:1685-92; discussion 1692.
6. de Perrot M, Feld R, Cho BC, et al. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol 2009;27:1413-1418.
7. Krug LM, Pass HI, Rusch VW, et al: Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. Journal of Clinical Oncology 27:3007-3013, 2009.
8. Milano MT, Zhang H: Malignant pleural mesothelioma: a populationbased study of survival. Journal of Thoracic Oncology 5:1841, 2010
9. Cao CQ, Yan TD, Bannon PG, et al. A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Oncol 2010;5:1692-1703.
10. Ahamad A, Stevens CW, Smythe WR, et al. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2003;55:768-775.
11. Miles EF, Larrier NA, Kelsey CR, et al. Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience. Int J Radiat Oncol Biol Phys 2008;71:1143-1150.
12. Allen AM, Czerminska M, Janne PA, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 2006;65:640-645.
13. Komaki R, Liao Z, Liu H, et al. Fatal pneumonitis associated with intensity- modulated radiation therapy for mesothelioma: in regard to Allen et al. Int J Radiat Oncol Biol Phys 2006;66:1595-1596.
14. Int J Radiat Oncol Biol Phys 2006;65:640-645.
15. Krayenbuehl J, Oertel S, Davis JB, et al. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy. Int J Radiat Oncol Biol Phys 2007;69:1593-1599.
16. Gupta V, Krug LM, Laser B, et al. Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapy. J Thorac Oncol 2009;4:746-750.
17. Scorsetti M, Bignardi M, Clivio A, et al. Volumetric Modulation Arc Radiotherapy Compared with Static Gantry Intensity-Modulated Radiotherapy for Malignant Pleural Mesothelioma Tumor: A Feasibility Study. Int J Radiat Oncol Biol Phy 2010;77:942-949.
18. Chi A, Liao Z, Nguyen NP, et al. Intensity-modulated radiotherapy after extrapleural pneumonectomy in the combined-modality treatment of malignant pleural mesothelioma. J Thorac Oncol 2011;6:1132-1141.
19. Tsao AS, Wistuba I, Roth JA, et al. Malignant pleural mesothelioma. J Clin Oncol 2009;27:2081-2090.
20. Tsao ASH, Saigal B, Liu S, et al. Activated Src kinase is expressed in malignant pleural mesothelioma tumors; dasatinib inhibition leads to cytotoxicity, cell cycle inhibition, and prevention of invasion and migration. J Clin Oncol 2007;25:7713.
21. Rusch VW, Venkatraman ES: Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 1999;68:1799-1804.
22. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-63.
23. Bolukbas S, Manegold C, Eberlein M, et al. Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy. Lung Cancer 2011;71:75-81.
24. Friedberg JS, Culligan MJ, Mick R, et al. Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma. Ann Thorac Surg 2012;93:1658-1665.
25. Lang-Lazdunski L, Bille A, Lal R, et al. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma. J Thorac Oncol 2012;7:737-743.
26. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-2644.